|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| A61K 39/00 | (2006.01) |
| (11) | Number of the document | 3802598 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19728454.0 |
| Date of filing the European patent application | 2019-06-07 | |
| (97) | Date of publication of the European application | 2021-04-14 |
| (45) | Date of publication and mention of the grant of the patent | 2025-02-12 |
| (46) | Date of publication of the claims translation | 2025-04-10 |
| (86) | Number | PCT/EP2019/064942 |
| Date | 2019-06-07 |
| (87) | Number | WO 2019/234220 |
| Date | 2019-12-12 |
| (30) | Number | Date | Country code |
| 18176888 | 2018-06-09 | EP | |
| 18176889 | 2018-06-09 | EP | |
| 19159321 | 2019-02-26 | EP |
| (72) |
HIPP, Susanne , DE
ADAM, Paul , DE
DZIEGELEWSKI, Michael , US
GANESAN, Rajkumar , US
GORMAN, Philip Nicholas , US
GUPTA, Priyanka , US
GUPTA, Pankaj , US
SCHEER, Justin , US
VOYNOV, Vladimir H. , US
|
| (73) |
Boehringer Ingelheim International GmbH ,
Binger Strasse 173, 55216 Ingelheim am Rhein,
DE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | DLL3/CD3 surišantys baltymai vėžio gydymui |
| DLL3/CD3 BINDING PROTEINS FOR CANCER TREATMENT |
| Payment date | Validity (years) | Amount | |
| 2025-05-23 | 7 | 162.00 EUR |
| 2026-06-07 |